New model suggests feared side effect of Alzheimer's drugs is unlikely
Thursday, June 17, 2010 - 15:50
in Health & Medicine
The first trial of a new model for testing Alzheimer's treatments has reassured researchers that a promising class of drugs does not exacerbate the disease if treatment is interrupted.